ENSC compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name

ENSCEnsysce Biosciences, Inc.

Mkt capRevenueRevenue

LLYELI Lilly & Co

Mkt capRevenueRevenue

Compare

ENSCEnsysce Biosciences, Inc.

LLYELI Lilly & Co

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

ENSCEnsysce Biosciences, Inc.

0.37▼−4.42%· post 0.38· delayed

Mkt cap$8.2MRevenue$1,497Q4 FY23Revenue—

LLYELI Lilly & Co

1,407.25▼−0.27%· post 1,407.00· delayed

After hoursNov 3 '26delayed

Mkt cap$1.3TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

Compare

After hoursNov 3 '26delayed

ENSCEnsysce Biosciences, Inc.

LLYELI Lilly & Co

0.37▼−4.42%post 0.38delayed

Price

1,407.25▼−0.27%post 1,407.00delayed

$8.2M

Mkt cap

$1.3T

Q4 FY23$1,497

Revenue

$24.4BQ3 FY26

—

Revenue

$65.2BFY25

ENSC0.37▼−4.42%vsLLY1,407.25▼−0.27%After hoursNov 3 '26delayed

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

ENSC: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only ENSC 0

None

Shared 0

No disclosed counterparties: ENSC.

Only LLY 29

MCKMcKessoncustomer

CAHCardinal Healthcustomer

VEEVVeeva Systemssupplier

UTHRUnited Therapeuticscustomer

25 more · LLY chain ›

Role chip = supplier or customerSource: SEC EDGAR

Price

rebased to 0%

ENSC, solidLLY, dashed